BioSpace News Archive

Labcorp announced the launch and availability of a new, FDA-cleared blood test for risk assessment and clinical management of severe preeclampsia, a life-threatening blood pressure disorder that occurs during pregnancy and the postpartum period.

Hyalex Orthopaedics, a privately held medical device company developing cartilage repair products based on the transformative HYALEX® materials platform, today announced that Carl Vause, the company’s president and chief executive officer, will deliver a corporate presentation as part of the Canaccord Genuity 2024 Musculoskeletal Conference.

REGENXBIO Inc. announced presentations on its program for the treatment of mucopolysaccharidosis type II, also known as Hunter syndrome, will be shared at the 20th Annual WORLDSymposium™ 2024, taking place in San Diego, CA February 3-9, 2024.

Passage Bio, Inc. today announced that William Chou, M.D., president and chief executive officer, will participate in a fireside chat at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference on Thursday, February 8, 2024 at 10:00 a.m. ET.

Biogen Inc. (Nasdaq: BIIB) today announced plans to reprioritize its resources in Alzheimer’s disease (AD), a strategic therapeutic area expected to drive near and long-term growth.

Neurimmune announced today that it regained global rights to aducanumab, a recombinant human antibody developed to deplete brain amyloid.

Cabaletta Bio, Inc. today announced that Steven Nichtberger, M.D., Chief Executive Officer, will participate in a fireside chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference on Wednesday, February 7, 2024 at 10:00 a.m. ET in New York, NY.

Rhythm Pharmaceuticals, Inc. today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, February 22, 2024 to report its fourth quarter and full year 2023 financial results and provide a corporate update.

Arcutis Biotherapeutics, Inc. today announced that Arcutis management will participate in the Guggenheim Healthcare Talks – 6th Annual Biotechnology Conference.

Gain Therapeutics, Inc. today releases the following letter to stockholders from its President and Chief Executive Officer Matthias Alder.